Back to Results
First PageMeta Content
Hepatology / Nursing research / Milk thistle / National Center for Complementary and Alternative Medicine / Silybum marianum / Flavonolignans / Hepatocellular carcinoma / Hepatitis / Silibinin / Medicine / Health / Medicinal plants


DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH NATIONAL CENTER FOR COMPLEMENTARY AND ALTERNATIVE MEDICINE NATIONAL ADVISORY COUNCIL FOR COMPLEMENTARY AND ALTERNATIVE MEDICINE
Add to Reading List

Document Date: 2012-01-03 10:44:01


Open Document

File Size: 41,23 KB

Share Result on Facebook

City

San Francisco / Tucson / Dallas / Davenport / Portland / Durham / Baltimore / Temple / New York / Los Angeles / /

Company

Agency for Healthcare Research / D. / /

Country

United States / /

Event

Person Communication and Meetings / /

Facility

National Institute of Diabetes / University of Maryland / /

IndustryTerm

hepatitis C therapy / therapy for hepatitis C / potential clinical protocols / chemical constituents / chosen product / clinical trial protocol / standardized milk thistle product / chemical toxicity / clinical protocol / silymarin product / actual protocols / treatment of liver disorders / potential protocols / milk thistle product / standardized product / treatment of hepatitis / /

MedicalCondition

mixed disease / notably chronic hepatitis C / cirrhosis / hepatitis / end-stage liver disease / virus viremia / liver disease / common chronic liver disease / progressive hepatic fibrosis / different diseases / hepatocellular carcinoma / Liver Diseases / certain hepatitis C / diabetes / chronic liver diseases / alcohol-related liver disease / alcoholic disease / viral hepatitis / common liver disease / drug-induced disease / hepatitis C / naive hepatitis C / liver disorders / standard hepatitis C / obesity / MS / hepatic fibrosis / disease / chronic liver disease / Kidney Diseases / viral disease / mushroom poisoning / cellular injury / alcoholic hepatitis / liver injury / anemia / chronic hepatitis C / /

MedicalTreatment

dietary supplement / complementary therapy / clinical protocol / clinical protocols / /

Organization

Council Discussion Council / University of Maryland / Division of Extramural Activities / Protocol Writing Committee / National Center for Complementary / National Institute of Diabetes & Digestive / National Advisory Council for Complementary / National Advisory Council for Complementary and Alternative Medicine / FDA / Present National Center for Complementary and Alternative Medicine / Alternative Medicine / National Institute of Health / IRBs / National Center for Complementary and Alternative Medicine / DSMB / Council on the Notice of Opportunity / office of Clinical and Regulatory Affairs / DEPARTMENT OF HEALTH AND HUMAN SERVICES / Agency for Healthcare Research and Quality / /

Person

Camille Hoover / Clinton / Stefanie N. Vogel / Gerald Cross / Chris Thomsen / Deborah J. Cotton / Amer J Gastroenterol / Benjamin Yang / Simon Weavers / Murray Goldstein / Alan Leshner / Barbara Timmermann / Stephen Straus / Jeanette Ezzo / Linda Rich / Carol Fitzpatrick / Josh Berman / Robert E. Fullilove / Jane F. Kinsel / Leslie Hillis / Michael Irwin / George Tucker / Richard Niemtzow / Larry Walker / Joel Pickar / Zang-Hee Cho / Margaret Chesney / Strickland / Jonathan Davidson / Qi-Ying Liu / Michelle Rodrigues / Linda Engel / Kristina Collins / Stephen E. Straus / Carlo Calabrese / Jane Kinsel / /

Position

advisor / Executive Secretary / Program Officer / Deputy Director / Director / Chair / Ph. Executive Secretary / M. Chair / /

Product

ribavirin / /

ProgrammingLanguage

DC / /

ProvinceOrState

New York / Maryland / /

Technology

actual protocols / potential clinical protocols / 5 Protocol / clinical protocol / clinical trial protocol / ultrasound / pharmacokinetics / /

SocialTag